<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView%20%20&amp;noscript=1">
  • There are no suggestions because the search field is empty.

While syngeneic tumor model use is widespread in preclinical immunotherapy drug development, there are concerns about the translatability of the models.
© 2026 Crown Bioscience. All Rights Reserved.